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data  are  available  on  the  carriage  of  pneumococcal  serotypes  in  Morocco.  Here,
we  describe  the  prevalence  of  Streptococcus  pneumoniae  carriage  and  serotype
distribution  among  697  pediatric  patients  with  ages  ranging  from  2  to  59  months
who  were  admitted  to  a Moroccan  hospital  with  severe  pneumonia,  as  well  as  195
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Background
Pneumococcal  disease  is  the  leading  cause  of
vaccine  preventable  deaths,  and  Streptococcus
pneumoniae  is  estimated  to  be  responsible  for  11%
of all  deaths  in  children  less  than  ﬁve  years  of
age worldwide,  mostly  due  to  community-acquired
pneumonia  [1]. Nasopharyngeal  colonization  is
known to  play  an  important  role  in  the  develop-
ment and  transmission  of  pneumococcal  disease.
Infants and  young  children  are  considered  to  be
the main  carriers  of  this  pathogen  [2].  Studies  show
that it is  essential  to  prospectively  monitor  circulat-
ing pneumococcal  serotypes  to  predict  and  assess
the impact  of  the  vaccine  introduction  in  a  given
community and  also  determine  whether  serotype
replacement may  be  occurring  [3].
Pediatric  pneumonia  remains  a  major  public
health challenge  in  Morocco;  a  middle-income
country in  Northern  Africa.  A  recent  study  con-
ducted in  2010  in  a  tertiary  hospital  that  involved
admitted children  less  than  ﬁve  years  of age
with clinically  severe  pneumonia  reported  that
the etiologies  of  pneumonia  were  mostly  viral.
Additionally, the  bacterial  pathogens  were  rarely
isolated,  affecting  only  3.5%  of  the  patients  [4]. In
2010, the  Moroccan  Ministry  of  Health  introduced
the pneumococcal  (13-valent)  conjugate  vaccine
into its  expanded  program  of  immunization  (EPI)
[5].  Due  to  the  lack  of  available  data  in  Morocco
[6],  we  aimed  to  investigate  pneumococcal  carriage
and serotype  distribution  among  healthy  infants
recruited at  vaccination  clinics  and  sick  children
admitted with  a  diagnosis  of  severe  pneumonia  at
a hospital  in  Morocco.
Material and methodsPlease  cite  this  article  in  press  as:  Jroundi  I,  et  al.  Strept
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Study region and population
The  study  was  conducted  at  the  Hôpitald’Enfants
de Rabat  (HER),  the  only  public  hospital  dedicated
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ildren  who  were  recruited  at  a  vaccination  clinic.  Car-
195)  for  healthy  children  and  22.8%  (159/697)  for  sick
ly  observed  circulating  serotypes  included  6A,  6B  and
 in  the  current  13-valent  anti-pneumococcal  conjugate
roduced  in  Morocco.  Monitoring  of  circulating  serotypes
ine  introduction  to  assess  whether  serotype  replacement
of  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.
o  children  in  the  region,  and  at  four  heath  centers
ocated  in  the  region  of  Rabat-Salé-Zemmour-Zair
RSZZ  Rabat  province).  The  proportion  of  children
nder ﬁve  in  the  region  of  RSZZ  has  been  estimated
o be  5.66%  [5].
tudy design
he  study  population  was  recruited  from  HER  and
onsisted  of  patients  admitted  for  severe  clinical
neumonia  according  to  WHO  deﬁnition  [7]  during  a
ne-year survey  from  November  2010  to  December
011. These  subjects  were  recruited  as  part  of  a
ider research  protocol  attempting  to  deﬁne  the
pidemiology  and  etiology  of  respiratory  distress  at
ER [4].  Healthy  children  who  were  visiting  primary
ealth  care  centers  in  the  province  of  Rabat  for  rou-
ine vaccination  were  also  recruited  from  February
o March  of  2011.  These  sites  were  selected  ran-
omly from  a list  of  primary  health  care  providers
n the  region  RSZZ.  The  sample  size  for  the  com-
unity study  (n  =  200)  was  calculated  based  on  the
reliminary  carriage  rates  observed  at  HER  in  chil-
ren with  WHO-deﬁned  severe  clinical  pneumonia
4].
ata collection
hildren  were  recruited  only  after  the  parents  or
egal guardians  signed  an  informed  consent  form.
he study  team  then  administered  standardized
uestionnaires  and  obtained  nasopharyngeal  sam-
les from  the  children  using  a mini  culturette
xtra-thin ﬂexible  wire  swab,  in  addition  to  other
rocedures  explained  elsewhere  [4].
aboratory methods
he  nasopharyngeal  cultures  were  added  to  tubes
ontaining  Stuart  Transport  Medium.  Samples  wereococcus  pneumoniae  carriage  among  healthy  and  sick
f  the  13-valent  pneumococcal  vaccine  in  Morocco  from
rg/10.1016/j.jiph.2016.02.012
rocessed  (homogenized,  aliquoted  and  frozen  at
70 ◦C)  on  a daily  basis.  Nasal  samples  were  cul-
ured using  conventional  methods  and  bacterial
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.  pneumoniae  carriage  among  healthy  and  sick  ped
solates  were  identiﬁed  by  analysis  of  colony  mor-
hology  and  biochemical  tests.  Molecular  capsular
yping  of  pneumococcal  strains  (isolated  by  con-
entional  culture)  was  performed  using  sequential
ultiplex real-time  PCR  targeting  24  common
erotypes (1,  3,  4,  5,  6A,  6B,  7F/A,  8,  9V/A/N/l,
4, 15B/C,  18C/B,  19A,  19F/B/C,  23A  and  23F)  [8].
ata analysis
tudy  variables  were  analyzed  and  summarized
n frequency  tables.  Quantitative  variables  are
xpressed  as  the  means  with  their  correspond-
ng standard  deviations.  Qualitative  variables  are
resented as  percentages  with  95%  conﬁdence
ntervals. Patients  from  peripheral  health  posts
ere included  to  provide  a  baseline  assessment
f carriage  rates  among  theoretically  healthy
hildren. This  study  was  not  designed  to  infer
ifferences or  associations;  therefore,  no  formal
tatistical comparisons  are  presented  between  the
roups.
esults
even  hundred  patients  who  were  eligible  for  the
tudy  were  admitted  for  severe  clinical  pneumo-
ia during  the  one-year  survey,  and  200  healthy
hildren were  recruited  from  primary  health  care
enters  during  a  one-month  period.  The  propor-
ion of  infants  less  than  one  year  of  age  was  30.6%
214/700) for  the  admitted  patients  and  70.7%
138/195)  for  the  children  from  the  community.
hree samples  from  the  hospitalized  group  and  ﬁve
rom the  outpatient  group  were  not  suitable  for
nalyses.  Thus,  nasopharyngeal  carriage  of  S.  pneu-
oniae was  22.8%  (159/697)  among  the  admitted
atients and  40.5%  (79/195)  among  the  children
ecruited from  the  primary  care  centers.
Among  admitted  patients,  the  monthly  distribu-
ion of  carriage  was  signiﬁcantly  different  (data
ot shown,  p  < 0.001),  and  carriage  was  signiﬁ-
antly more  frequent  during  the  spring  and  summer
∼31—32%)  than  during  the  autumn  and  winter
∼19—20%) (p  =  0.003).  Seasonality  could  not  be
ssessed  among  the  outpatients,  as  the  recruitment
eriod lasted  only  one  month.
Carriage  rates  also  varied,  albeit  not  signiﬁ-
antly, according  to  the  number  of  pneumococcal
accine doses  received.  Thus,  in  infants  the  car-Please  cite  this  article  in  press  as:  Jroundi  I,  et  al.  Strept
pediatric  patients  before  the  generalized  implementation  o
2010  to  2011.  J  Infect  Public  Health  (2016),  http://dx.doi.o
iage rates  were  21.2%,  24.5%,  31.3%  and  33%
mong those  who  received  zero,  one,  two  or  three
oses, respectively.  Of  the  children  who  were  over
ne year  of  age,  24.0%  of  the  children  who  had
t
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ot  received  any  doses  and  31.6%  of  the  children
ho had  received  one  dose  were  carriers.  However,
one of  the  children  who  had  received  at  least  two
oses were  positive.
Serotype  distribution  was  assessed  using  molec-
lar methods  in  74.2%  (118/159)  and  58.2%  (46/79)
f the  individuals  who  had  tested  positive  for  pneu-
ococcus. The  most  frequent  circulating  serotypes
ncluded  6A,  6B  and  19F/B/C.  The  proportion  of  the
arriage among  healthy  children  was  two  to  eight
imes higher  than  in  children  less  than  12  months  of
ge, while  the  distribution  of  19F/B/C  was  twofold
igher among  children  who  had  received  at  least
ne dose  of  the  13-valent  pneumococcal  conju-
ate vaccine.  In  this  population,  serotype  6A  was
imilarly  common,  but  6B  was  only  observed  in
ncompletely  (one  or  two  doses)  vaccinated  chil-
ren. For  the  children  whose  individual  serotype
ata were  not  available,  vaccine  coverage  for  the
irculating  serotypes  was  55.9%  (66/118)  among
ospitalized  children  and  52.1%  (24/46)  for  healthy
hildren.  We  also  observed  certain  serotypes  for
hich inter-group  differentiation  was  not  possible
ecause of  the  diagnostic  method  utilized  (i.e.,
9F/B/C).  Table  1  shows  the  characteristics  of  the
hildren included  in  this  study  and  the  distribution
f serotypes.
iscussion
ur  results  showed  moderately  low  nasal  car-
iage rates  of  pneumococci,  ranging  from  23%  to
0%, in  two  very  distinct  pediatric  populations:
ick children  with  severe  clinical  pneumonia  and
ealthy children.  This  analysis  provides  baseline
nformation on  the  current  status  of  pneumococ-
al carriage  among  children  in  Morocco.  However,
t is worth  noting  that  the  two  groups  studied
iffered signiﬁcantly  in  some  important  variables,
uch  as  socioeconomic  status  and  exposure  to
ntibiotics  or smoking.  These  differences  proba-
ly reﬂect  different  patterns  of  health  seeking
ehavior.
The predominant  serotypes  identiﬁed  in  these
opulations were  the  6A,  19F/B/C,  6B,  23A  and  23F
erotypes.  This  result  could  be  explained  by  the
act that  the  samples  were  obtained  shortly  after
he introduction  of  the  vaccine  to  the  EPI  sched-
le. Similar  results  were  observed  among  healthy
hildren  in  the  region  of  Marrakech  [9]  and  admit-
ed patients  in  Casablanca  [10]. At  least  half  ofococcus  pneumoniae  carriage  among  healthy  and  sick
f  the  13-valent  pneumococcal  vaccine  in  Morocco  from
rg/10.1016/j.jiph.2016.02.012
he individual  serotypes  identiﬁed  are  included  in
he current  vaccine  used  by  the  national  immuniza-
ion program  that  was  introduced  in  November  2010
11]. The  actual  coverage  of  circulating  serotypes
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Table  1  Baseline  characteristics  and  microbiological  ﬁndings  among  admitted  children  with  clinically  severe
pneumonia  and  healthy  patients.
Patient’s  variables  Hospitalized  patients
N  =  700
Healthy  community
controls
N  =  200
n/N  (%)  n/N  (%)
Basic  demographics
Female  gender  251/700  (35.9)  99/195  (50.8)
Age  in  months:  mean  (SD)  21.5  (14.5)  8.9  (11.1)
Infants  (<1  year) 214/700  (30.6) 138/195  (70.8)
Both  parents  unemployed 120/691  (17.4) 9/195  (4.6)
Both  parents  employed 58/691  (8.4) 48/195  (24.6)
Medical  insurance 181/696  (26.0) 92/193  (47.2)
Proportion  of  children  living  in  house  >6  people  268/700  (38.3)  49/195  (25.1)
Number  of  rooms  in  house:  mean  (SD)  2.2  (1.1)  1.8  (0.9)
Breast  feeding  >6  months  422/697  (60.5)  56/195  (28.7)
Prior  admission  due  to  respiratory  condition  227/700  (32.4)  18/194  (9.3)
Smokers  at  home  282/699  (40.3)  58/195  (29.7)
Pre-recruitment  use  of  antibiotics  206/700  (29.4)  34/195  (17.4)
At  least  one  dose  of  Pneumococcal  vaccine  117/700  (16.7)  137/195  (70.3)
Bacterial  carriage  in  the  nasopharynx
Positive  pneumococcus  in  NPA  159/697  (22.8)  79/195  (40.5)
Streptococcus  pneumoniae  serotype  distribution
Non-typable  pneumococci  41/159  (25.8)  33/79  (41.8)
Typable  pneumococci  118/159  (74.2)  46/79  (58.2)
18C/B  5/118  (4.2)  1/79  (1.3)
19F/B/C  22/118  (18.6)  11/79  (13.9)
23Aa 6/118  (5.1)  5/79  (6.3)
23F  11/118  (9.3)  3/79  (3.8)
4  —  1/79  (1.3)
6A  34/118  (28.8)  13/79  (16.5)
6B  21/118  (17.8)  10/79  (12.7)
8a —  1/79  (1.3)
9V/A/N/L  6/118  (5.1) 1/79  (1.3)
19A  10/118  (8.5) —
7FA 2/118  (1.7) —
3  1/118  (0.8) —
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ia Serotypes not included in the 13-valent pneumococcal con
of  this  vaccine  may  be  even  higher  in  Morocco,  as
some of  the  grouped  serotypes  that  were  identi-
ﬁed are  also  included  in  the  vaccine.  Consequently,
the wider  implementation  of  this  vaccine,  for  which
coverage  rates  were  still  low  among  admitted
patients with  severe  pneumonia  at  the  time  of  the
study, may  not  only  contribute  to  the  observed
decrease in  pneumococcal  associated  severe  dis-
ease but  also  decrease  asymptomatic  carriage  [12].
Once it  has  been  adequately  deployed  throughout
the country,  the  potential  public  health  impact  of
this vaccine  should  be  signiﬁcant.  Under  the  natural
conditions  of  exposure  in  low-  and  middle-incomePlease  cite  this  article  in  press  as:  Jroundi  I,  et  al.  Strept
pediatric  patients  before  the  generalized  implementation  o
2010  to  2011.  J  Infect  Public  Health  (2016),  http://dx.doi.o
countries,  children  quickly  become  colonized  by
pneumococci,  and  it  is not  uncommon  to  ﬁnd  mod-
erate to  high  carriage  rates  often  exceeding  2/3  of
the children,  particularly  among  young  infants,  in
A
I
tte vaccines.
ountries  that  have  not  yet  implemented  a vaccina-
ion program  [13]. In  our  study,  we  observed  lower
han expected  carriages  rates  of  the  serotypes  most
ommonly  described  in  the  literature  [13].  Contin-
ous monitoring  and  repeated  investigations  of  the
erotype distribution  of  pneumococcal  carriage  and
nvasive disease  remain  necessary  to  adequately
etect the  emergence  of  new  circulating  serotypes
n Morocco  [14],  to  prevent  further  morbidity  and
ortality  and  to  assess  the  impact  of  the  recently
mplemented vaccine.ococcus  pneumoniae  carriage  among  healthy  and  sick
f  the  13-valent  pneumococcal  vaccine  in  Morocco  from
rg/10.1016/j.jiph.2016.02.012
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